Jury Finds Pharma Exec 'Shadow Traded' With Inside Info
By Bonnie Eslinger
A California federal jury found Friday that a former Medivation executive is liable for using inside information from his company when he purchased stock in rival pharmaceutical maker Incyte, in a novel civil "shadow trading" case brought by the U.S. Securities and Exchange Commission.